» Articles » PMID: 36612264

Novel Strategies for the Bioavailability Augmentation and Efficacy Improvement of Natural Products in Oral Cancer

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Jan 8
PMID 36612264
Authors
Affiliations
Soon will be listed here.
Abstract

Oral cancer is emerging as a major cause of mortality globally. Oral cancer occupies a significant proportion of the head and neck, including the cheeks, tongue, and oral cavity. Conventional methods in the treatment of cancer involve surgery, radiotherapy, and immunotherapy, and these have not proven to completely eradicate cancerous cells, may lead to the reoccurrence of oral cancer, and possess numerous adverse side effects. Advancements in novel drug delivery approaches have gained popularity in cancer management with an increase in the number of cases associated with oral cancer. Natural products are potent sources for drug discovery, especially for anticancer drugs. Natural product delivery has major challenges due to its low solubility, poor absorption, inappropriate size, instability, poor permeation, and first-pass metabolism. Therefore, it is of prime importance to investigate novel treatment approaches for the delivery of bioactive natural products. Nanotechnology is an advanced method of delivering cancer therapy with minimal damage to normal cells while targeting cancer cells. Therefore, the present review elaborates on the advancements in novel strategies for natural product delivery that lead to the significant enhancement of bioavailability, in vivo activity, and fewer adverse events for the prevention and treatment of oral cancer. Various approaches to accomplish the desired results involve size reduction, surface property modification, and polymer attachment, which collectively result in the higher stability of the formulation.

Citing Articles

Phytochemical analysis, antioxidant activity, and cytotoxic effects of Caulerpa lentillifera extracts inducing cell apoptosis and sub-G/G0-G1 cell cycle arrest in KON oral cancer cells.

Manmuan S, Sirirak T, Tubtimsri S, Petchsomrit A, Chuenbarn T BMC Complement Med Ther. 2025; 25(1):101.

PMID: 40069755 PMC: 11899751. DOI: 10.1186/s12906-025-04835-9.


Molecular Targets of Plant-Derived Bioactive Compounds in Oral Squamous Cell Carcinoma.

Mitea G, Schroder V, Iancu I, Miresan H, Iancu V, Bucur L Cancers (Basel). 2024; 16(21).

PMID: 39518052 PMC: 11545343. DOI: 10.3390/cancers16213612.


Anticancer Potential of Quercetin on Oral Squamous Cell Carcinoma: A Scoping Review and Molecular Docking.

Afriza D, Arma U, Faslah R, Suriyah W Eur J Dent. 2024; 19(1):15-23.

PMID: 39348855 PMC: 11750326. DOI: 10.1055/s-0044-1789016.


Nanomedicine-based cancer immunotherapy: a bibliometric analysis of research progress and prospects.

Chen C, Yuan P, Zhang Z Front Immunol. 2024; 15:1446532.

PMID: 39247199 PMC: 11377264. DOI: 10.3389/fimmu.2024.1446532.


Natural Products in the Treatment of Retinopathy of Prematurity: Exploring Therapeutic Potentials.

Heo J, Ryu J Int J Mol Sci. 2024; 25(15).

PMID: 39126030 PMC: 11313229. DOI: 10.3390/ijms25158461.


References
1.
Mao L, Lee J, Fan Y, Ro J, BATSAKIS J, Lippman S . Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med. 1996; 2(6):682-5. DOI: 10.1038/nm0696-682. View

2.
Kreimer A, Clifford G, Boyle P, Franceschi S . Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005; 14(2):467-75. DOI: 10.1158/1055-9965.EPI-04-0551. View

3.
Kresty L, Mallery S, Stoner G . Black raspberries in cancer clinical trials: Past, present and future. J Berry Res. 2016; 6(2):251-261. PMC: 5008867. DOI: 10.3233/JBR-160125. View

4.
Schildt E, Eriksson M, Hardell L, Magnuson A . Oral infections and dental factors in relation to oral cancer: a Swedish case--control study. Eur J Cancer Prev. 1998; 7(3):201-6. DOI: 10.1097/00008469-199806000-00004. View

5.
Ghanbari-Movahed M, Mondal A, Farzaei M, Bishayee A . Quercetin- and rutin-based nano-formulations for cancer treatment: A systematic review of improved efficacy and molecular mechanisms. Phytomedicine. 2022; 97:153909. DOI: 10.1016/j.phymed.2021.153909. View